EFEhsan Mosa Farkhani

Ehsan Mosa Farkhani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ehsan Mosa Farkhani has a total of 91 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    True Versus Sham Thread Embedding Acupuncture for Spasticity-Related Symptoms and Disabilities in Multiple Sclerosis: Study Protocol of a Randomized Controlled Trial

    by Malika Vaez-Tehrani, Mohammad Ali Nahayati, Ehsan Mosa-Farkhani, Shirin Shafaei, Mohammad Nematshahi, Hamidreza Bahrami-Taghanaki

    Introduction: Multiple sclerosis (MS) is a chronic autoimmune disease and one of the most common causes of non-traumatic disability in young adults, with over 2.8 million individuals worldwide. Spasticity affects nearly 80% of people with MS (PwMS), contributing to pain, gait disturbance, bowel/bladder dysfunction, sleep/mood disorders, and impaired quality of life. The complex condition known as Spasticity-Plus syndrome is gaining attention. Current pharmacological treatments are limited by side effects and short duration of benefits. Thread Embedding Acupuncture (TEA), which involves embedding absorbable polydioxanone (PDO) sutures into acupoints, offers prolonged stimulation and has shown promise in managing spasticity, particularly after stroke. Several randomized controlled trials (RCTs) have reported positive effects in MS. This is a study that protocol aims to evaluate the efficacy and safety of True TEA (TTEA) compared with Sham TEA (STEA) in reducing spasticity and improving mobility and related symptoms among PwMS. Methods: This is a protocol of a randomized, sham-controlled, patient-, assessor- and analyst-blinded, superiority clinical trial. Thirty-eight eligible PwMS with moderate-to-severe spasticity will be randomized 1:1 to either TTEA or STEA. Both groups will undergo puncture at the same 30 acupoints but only the TTEA group will receive PDO thread implantation. The primary outcome is change in disability (EDSS). Secondary outcomes are Numeric Rating Scale for Spasticity (NRS-S), walking ability (MSWS-12), activities of daily living (Barthel Index), pain (McGill Pain Questionnaire), fatigue (MFIS), sleep quality (PSQI), urinary symptoms (ABSST), mood (HADS), quality of life (EQ-5D-5L), overall treatment satisfaction, willingness to repeat and recommendation to others. Assessments will be conducted at baseline, 4 weeks, and 12 weeks post-intervention. Intention-to-treat analysis will be performed. Perspective: To our knowledge this trial will be the first RCT to evaluate TEA in spasticity-related symptoms in PwMS. By using a sham-controlled design, it will determine whether TEA confers benefits beyond needle puncture alone. Findings may provide evidence for incorporating TEA as a complementary option in MS symptom management and inform future larger-scale trials. Trial registration: IRCT20121228011912N8 (22 March 2024; Updated: 13 July 2026).

  • Open Access

    Association between gestational diabetes mellitus and adverse pregnancy outcomes and effect modification by maternal age in a population based cohort study

    by Amin Moradi, Shaghayegh Afzalnia, Ehsan Mosa Farkhani, Mehdi Norouzi

    Gestational diabetes mellitus (GDM) is a rising public health issue and comes with many negative pregnancy effects for both mothers and infants. Because there is an increasing pattern in advanced maternal age around the globe, it has become very important to know whether age changes the effect of GDM on pregnancy outcomes. This study aimed to look at the links between GDM and major maternal and neonatal complications in a large population-based cohort and see if maternal age modifies this relationship. This population-based cohort study was carried out using Sina electronic health records and what we found was after carefully applying the inclusion and exclusion criteria we had set, a total of 424,359 pregnant women made the cut. A diagnosis of GDM was made according to the strict criteria laid out by the International Association of Diabetes and Pregnancy Study Groups (also known as the IADPSG ones) The study focused on various negative outcomes including Caesarean sections, premature births, low birth weights, babies being over-sized for their gestational age, admissions to the neonatal ICU and a range of hypertensive disorders. We plumped for logistic regression models to work out adjusted odds ratios (the fancy bit is that we tried to remove other possible factors that could have had an influence on the results) and 95% confidence intervals to see how reliable our findings were. To see whether the presence of GDM interacted with age of the mother we looked at two age groups < 35 years and ≥ 35 years. We did this by including a multiplicative interaction term in our analysis. Among the total cohort, 19,861 women (4.7%) had GDM.After full adjustment for sociodemographic, behavioral and clinical factors, GDM was associated with significantly higher odds of cesarean delivery (aOR 1.79, 95% CI 1.73−1.84; P < 0.001), preterm birth (aOR 1.76, 95% CI 1.66−1.86; P < 0.001), LBW (aOR 1.15, 95% CI 1.08−1.22; P < 0.001), macrosomia (aOR 1.75, 95% CI 1.66−1.85; P < 0.001), NICU admission (aOR 1.38, 95% CI 1.32−1.44; P < 0.001) and HDP (aOR 2.44, 95% CI 2.29−2.60; P < 0.001). In age stratified analyses, GDM remained associated with all adverse outcomes in both groups. A statistically significant interaction with maternal age was observed only for macrosomia (p-value for interaction term = 0.007), with a stronger association among women < 35 years (aOR 1.82, 95% CI 1.68−1.98) than among women ≥ 35 years (aOR 1.63, 95% CI 1.51–1.75). GDM was associated with higher risks of serious health problems for mothers and newborns in this large study. Younger mothers were more likely to have heavier babies as a result of GDM, but most associations were not modified by the mothers age. The study shows that GDM affects women of all ages. But it also indicates that fetal overgrowth has a tendency to occur in younger women with GDM.


  • Open Access

    Climate change and cardiovascular diseases: a review of systemic challenges, policies, and management strategies

    by Amir Ghasemian, Ehsan Mousa Farkhani, Elaheh Hooshmand, Mansoureh Kouhi, Mehrdad Salehi, Seyed Saeed Tabatabaee, Javad Moghri

  • Open Access

    Nursing Care in Nosocomial Dengue: A One Health Approach

    by Abolghasem Shokri, Faranak Shokri, Alireza Bahonar, Ebrahim Rahimi, Ehsan Mosa Farkhani, Saied Bokaie

  • Open Access

    Parkinson’s disease mortality and years of potential life lost in Iran: A 10-year national analysis (2013–2023)

    by Faezeh Sadeghzadeh, Mahdieh Sahebi, Mahin Ghavami, Elaheh Kazemi, Hamed Etemadi, Fatemeh Zahra Nezamdoust, Ehsan Mosa Farkhani

    Background: Parkinson’s disease (PD) is a leading neurodegenerative disorder associated with increasing global morbidity and premature mortality. Despite its growing burden, national trends in PD-related mortality and years of potential life lost (YPLL) remain understudied in Iran. Objectives: To examine temporal trends in PD-related mortality and YPLL in Iran from 2013 to 2023 and to assess demographic and regional disparities. Methods: This repeated cross-sectional study used data from the Iranian National Death Registration System. All deaths attributed to PD (ICD-10 codes G20 and G21) between 2013 and 2023 were included. Crude age-specific and cause-specific mortality rates were calculated, and YPLL was estimated using standard methods. Temporal trends were assessed using regression-based analyses. Spatial patterns were evaluated using ArcGIS, and statistical analyses were performed in Stata version 17. Results: A total of 9229 PD-related deaths were recorded. Crude mortality rates increased from 0.21 per 100,000 in 2013 to 1.77 in 2023, while YPLL rose from 1.21 to 7.86 per 100,000. Males consistently exhibited higher mortality and YPLL than females. Geospatial analysis identified higher burdens in Tehran, Khorasan Razavi, Isfahan, and Fars. Lower rates in several rural provinces may partly reflect underreporting or disparities in healthcare access. Conclusion: The observed increase in crude PD-related mortality and YPLL over the past decade suggests a growing public health challenge in Iran. However, these trends should be interpreted with caution, as they may be influenced by population aging, improvements in diagnosis, and changes in death registration practices. Strengthening early diagnosis, specialized care, and equitable access to neurological services—particularly in underserved regions—remains a public health priority.

  • Open Access

    Epidemiological pattern of death and causes of death in registered immigrants of Northeast Iran during the 2013–2023: a cross-sectional study

    by Samaneh Eslami, Ehsan Mosa Farkhani, Masoumeh Sadeghi, Masoumeh Andish, Najmeh Khodadadi, Mohsen Dehghani

    International migration has increased in recent years and yet there is limited information about immigrant mortality. The present study aimed to investigat

  • Top Cited Papers
    Open Access

    Impact of gestational weight gain on adverse pregnancy outcomes in women with gestational diabetes: a retrospective cohort study

    by Amin Moradi, Mehdi Norouzi, Ehsan Mosa Farkhani

    This study focuses on determining the relationships between gestational weight gain(GWG) that falls within, below, or exceeds the Institute of Medicine(IOM


  • Open Access

    Investigating the nutritional and mental health status in the suburbs of Northeast Iran: a register-based study

    by Masoumeh Andish, Ehsan Mosa Farkhani, Ali Taghipoor, Samaneh Eslami, Zahra Amiri, Najmeh Khodadadi, Mohsen Dehghani

    In urban areas, particularly among informal settlements, malnutrition and mental health disorders are recognized as key indicators of social inequality. Ch


  • Open Access

    Prediction of Mortality in Iranian Elderly Using Frailty Index

    by Mehdi Norouzi, Zahra Amiri, Mohammad Hossein Madahali, Ehsan Mosafarkhani

    Introduction: Frailty in older adults can lead to severe outcomes such as early death, loss of function, and mental health issues. This study aims to predict mortality rates in elderly Iranians using the Frailty Index. Methods: This retrospective cohort study analyzed data from the Sina healthcare system, focusing on individuals aged 60 and above residing in nursing homes from 2020 to 2023. A total of 3554 elderly individuals were included, with frailty assessed using Fried’s scale. Data analysis was performed using Python 3.12, utilizing Kaplan-Meier survival analysis, log-rank tests, and Cox regression models to evaluate survival rates and the impact of frailty on mortality. Results: Of the 3,554 individuals assessed, 1,830 (51.50%) were identified as frail, and 36.50% of the total participants died during the follow-up period. The cumulative survival rates for frail individuals at 365,730, and 920 days were 0.62, 0.47, and 0.46, respectively, which were lower than those classified as healthy. Multivariable Cox regression analysis showed that frail individuals had a 2.04 times higher risk of mortality compared to healthy individuals, adjusting for confounding variables. Significant factors associated with increased mortality included being female, age over 70, and presence of co-morbidities, while literacy was identified as a protective factor. Conclusion: Frailty is strongly associated with increased mortality risk in the elderly. The frailty index is an effective predictor of mortality, highlighting the need for early identification and management of frailty to improve health outcomes in this population.